Vaccines for Hepatitis A, B, and E
Vaccination against hepatitis A should be part of a comprehensive plan for the prevention and control of viral hepatitis, including measures to improve safe drinking-water, sanitation and hygiene (such as hand washing) and measures for outbreak control.
WHO recommends that vaccination against hepatitis A virus be introduced into national immunization schedules for individuals aged ≥12 months, if indicated on the basis of: i) an increasing trend over time of acute hepatitis A disease, including severe disease, among older children, adolescents or adults; ii) changes in the endemicity from high to intermediate; and iii) considerations of cost–effectiveness.
For children, inactivated hepatitis A vaccines can be given as a single- or two-dose (off-label) schedule, and administered intramuscularly. With a two-dose schedule, the first dose should be given starting from age ≥12 months.
In highly endemic countries, most individuals are asymptomatically infected with HAV in childhood, which prevents clinical hepatitis A in adolescence and adulthood. In these countries, large-scale hepatitis A vaccination programmes are not routinely recommended, because they carry a risk of a paradoxical increase in disease incidence in unvaccinated people.
Countries with improving socioeconomic status may rapidly move from high to intermediate hepatitis A endemicity, rendering a larger proportion of the adolescent and/or young adult population susceptible to HAV infection. In such countries, large-scale hepatitis A vaccination in early childhood is likely to be cost–effective and is therefore recommended.
WHO Position Paper
Other publications - Hepatitis A
Several hepatitis B vaccines are available internationally. Both monovalent and products with multiple antigens are highly immunogenic and vaccination in a series of three doses will generate long-lasting, possibly life-long, protection against hepatitis B.
Vaccination against hepatitis B should be part of a comprehensive plan for the prevention and control of viral hepatitis, including measures for blood safety.
WHO recommends that all infants should receive their first dose of Hepatitis B vaccine as soon as possible after birth, preferably within 24 hours. The birth dose should be followed by 2 or 3 doses to complete the primary series. WHO also recommends that all health care workers receive this vaccine to prevent the risk of Hepatitis B in health care settings.
WHO Position Paper
Publications - Hepatitis B
This document provides guidance for immunization managers and maternal child health partners seeking to introduce hepatitis B birth dose vaccination into...
This review summarizes and appraises the evidence from published and grey literature on improving coverage of the hepatitis B birth dose. Specifically,...
This document is designed to supplement the sample design, sample selection and sample size determination guidance provided by the World Health Organization...
This document is specifically about impact assessment through serosurveys. This may be a standalone method or as part of a broader evaluation of hepatitis...
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising...
Hepatitis B virus (HBV) is transmitted by exposure of mucosal membranes or non-intact skin to infected blood or other body fluids....
News
Q & As on hepatitis b
Currently, there are no WHO pre-qualified vaccines against hepatitis E. In 2011, the first vaccine to prevent hepatitis E infection was registered in China.
A Strategic Advisory Group of Experts (SAGE) on Immunization Working Group on Hepatitis E was established in October 2013 to review the existing data on the safety, immunogenicity, efficacy, and cost-effectiveness of the hepatitis E vaccine. The target date for publication of the WHO position paper on hepatitis E vaccine is early 2015.
In the absence of internationally available vaccines, WHO recommends prevention of hepatitis E infection and transmission by maintaining quality standards for public water sources and proper disposal of sanitary waste, as well as maintenance of personal hygiene practice and avoiding drinking water and/or ice of unknown purity while in areas of high endemicity.
WHO Position Paper
Publications - Hepatitis E
Hepatitis E virus (HEV) is a major cause of sporadic and epidemic hepatitis that is found worldwide, the highest sero-prevalence rates being observed in...
Q & As on hepatitis E
Hepatitis - further information